• Je něco špatně v tomto záznamu ?

Expression Profile of Six RNA-Binding Proteins in Pulmonary Sarcoidosis

Z. Navratilova, E. Novosadova, M. Hagemann-Jensen, S. Kullberg, V. Kolek, J. Grunewald, M. Petrek,

. 2016 ; 11 (8) : e0161669. [pub] 20160830

Jazyk angličtina Země Spojené státy americké

Typ dokumentu srovnávací studie, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17031469

BACKGROUND: Sarcoidosis is characterised by up-regulation of cytokines and chemokine ligands/receptors and proteolytic enzymes. This pro-inflammatory profile is regulated post-transcriptionally by RNA-binding proteins (RBPs). We investigated in vivo expression of six RBPs (AUF1, HuR, NCL, TIA, TIAR, PCBP2) and two inhibitors of proteolytic enzymes (RECK, PTEN) in pulmonary sarcoidosis and compared it to the expression in four control groups of healthy individuals and patients with other respiratory diseases: chronic obstructive pulmonary disease (COPD), asthma and idiopathic interstitial pneumonias (IIPs). METHODS: RT-PCR was used to quantify the mRNAs in bronchoalveolar (BA) cells obtained from 50 sarcoidosis patients, 23 healthy controls, 30 COPD, 19 asthmatic and 19 IIPs patients. Flow cytometry was used to assess intracellular protein expression of AUF1 and HuR in peripheral blood T lymphocytes (PBTLs) obtained from 9 sarcoidosis patients and 6 healthy controls. RESULTS: Taking the stringent conditions for multiple comparisons into consideration, we consistently observed in the primary analysis including all patients regardless of smoking status as well as in the subsequent sub-analysis limited for never smokers that the BA mRNA expression of AUF1 (p<0.001), TIA (p<0.001), NCL (p<0.01) and RECK (p<0.05) was decreased in sarcoidosis compared to healthy controls. TIA mRNA was also decreased in sarcoidosis compared to both obstructive pulmonary diseases (COPD and asthma; p<0.001) but not compared to IIPs. There were several positive correlations between RECK mRNA and RBP mRNAs in BA cells. Also sarcoidosis CD3+, CD4+ and CD8+ PBTLs displayed lower mean fluorescence intensity of AUF1 (p≤0.02) and HuR (p≤0.03) proteins than control healthy PBTLs. CONCLUSION: mRNA expressions of three RBPs (AUF1, TIA and NCL) and their potential target mRNA encoding RECK in BA cells and additionally protein expression of AUF1 and HuR in PBTLs were down-regulated in our sarcoidosis patients compared to healthy individuals. Its significance, e.g. for stability of mRNAs encoding pro-inflammatory factors, should be further explored in sarcoidosis.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17031469
003      
CZ-PrNML
005      
20171025123018.0
007      
ta
008      
171025s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0161669 $2 doi
035    __
$a (PubMed)27575817
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Navratilova, Zdenka $u Laboratory of Immunogenomics and Immunoproteomics, Department of Pathological Physiology, Faculty of Medicine and Dentistry Palacky University, Olomouc, Czech Republic. Respiratory Medicine Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden. Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
245    10
$a Expression Profile of Six RNA-Binding Proteins in Pulmonary Sarcoidosis / $c Z. Navratilova, E. Novosadova, M. Hagemann-Jensen, S. Kullberg, V. Kolek, J. Grunewald, M. Petrek,
520    9_
$a BACKGROUND: Sarcoidosis is characterised by up-regulation of cytokines and chemokine ligands/receptors and proteolytic enzymes. This pro-inflammatory profile is regulated post-transcriptionally by RNA-binding proteins (RBPs). We investigated in vivo expression of six RBPs (AUF1, HuR, NCL, TIA, TIAR, PCBP2) and two inhibitors of proteolytic enzymes (RECK, PTEN) in pulmonary sarcoidosis and compared it to the expression in four control groups of healthy individuals and patients with other respiratory diseases: chronic obstructive pulmonary disease (COPD), asthma and idiopathic interstitial pneumonias (IIPs). METHODS: RT-PCR was used to quantify the mRNAs in bronchoalveolar (BA) cells obtained from 50 sarcoidosis patients, 23 healthy controls, 30 COPD, 19 asthmatic and 19 IIPs patients. Flow cytometry was used to assess intracellular protein expression of AUF1 and HuR in peripheral blood T lymphocytes (PBTLs) obtained from 9 sarcoidosis patients and 6 healthy controls. RESULTS: Taking the stringent conditions for multiple comparisons into consideration, we consistently observed in the primary analysis including all patients regardless of smoking status as well as in the subsequent sub-analysis limited for never smokers that the BA mRNA expression of AUF1 (p<0.001), TIA (p<0.001), NCL (p<0.01) and RECK (p<0.05) was decreased in sarcoidosis compared to healthy controls. TIA mRNA was also decreased in sarcoidosis compared to both obstructive pulmonary diseases (COPD and asthma; p<0.001) but not compared to IIPs. There were several positive correlations between RECK mRNA and RBP mRNAs in BA cells. Also sarcoidosis CD3+, CD4+ and CD8+ PBTLs displayed lower mean fluorescence intensity of AUF1 (p≤0.02) and HuR (p≤0.03) proteins than control healthy PBTLs. CONCLUSION: mRNA expressions of three RBPs (AUF1, TIA and NCL) and their potential target mRNA encoding RECK in BA cells and additionally protein expression of AUF1 and HuR in PBTLs were down-regulated in our sarcoidosis patients compared to healthy individuals. Its significance, e.g. for stability of mRNAs encoding pro-inflammatory factors, should be further explored in sarcoidosis.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a bronchiální astma $x genetika $x metabolismus $7 D001249
650    _2
$a HuR protein $x genetika $x metabolismus $7 D000067780
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a GPI-vázané proteiny $x genetika $x metabolismus $7 D058851
650    _2
$a stanovení celkové genové exprese $x metody $7 D020869
650    _2
$a regulace genové exprese $7 D005786
650    _2
$a heterogenní jaderný ribonukleoprotein D $x genetika $x metabolismus $7 D034502
650    _2
$a lidé $7 D006801
650    _2
$a idiopatické intersticiální pneumonie $x genetika $x metabolismus $7 D054988
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a fosfohydroláza PTEN $x genetika $x metabolismus $7 D051059
650    _2
$a fosfoproteiny $x genetika $x metabolismus $7 D010750
650    _2
$a poly(A)-vazebné proteiny $x genetika $x metabolismus $7 D039102
650    _2
$a chronická obstrukční plicní nemoc $x genetika $x metabolismus $7 D029424
650    _2
$a proteiny vázající RNA $x genetika $x metabolismus $7 D016601
650    _2
$a plicní sarkoidóza $x genetika $x metabolismus $7 D017565
650    _2
$a T-lymfocyty $x metabolismus $7 D013601
650    _2
$a mladý dospělý $7 D055815
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
700    1_
$a Novosadova, Eva $u Laboratory of Immunogenomics and Immunoproteomics, Department of Pathological Physiology, Faculty of Medicine and Dentistry Palacky University, Olomouc, Czech Republic.
700    1_
$a Hagemann-Jensen, Michael $u Respiratory Medicine Unit, Department of Medicine, Solna & Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
700    1_
$a Kullberg, Susanna $u Respiratory Medicine Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
700    1_
$a Kolek, Vitezslav $u Department of Respiratory Medicine, Palacky University, Olomouc, Czech Republic.
700    1_
$a Grunewald, Johan $u Respiratory Medicine Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
700    1_
$a Petrek, Martin $u Laboratory of Immunogenomics and Immunoproteomics, Department of Pathological Physiology, Faculty of Medicine and Dentistry Palacky University, Olomouc, Czech Republic. Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 11, č. 8 (2016), s. e0161669
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27575817 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20171025 $b ABA008
991    __
$a 20171025123059 $b ABA008
999    __
$a ok $b bmc $g 1255062 $s 992496
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 11 $c 8 $d e0161669 $e 20160830 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
LZP    __
$a Pubmed-20171025

Najít záznam

Citační ukazatele

Možnosti archivace